Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

9amHealth vs Signos

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.6

9amHealth

Best for Insured patients wanting branded GLP-1s within a full cardiometabolic care program
★★★3.8

Starting at $149/mo

Branded GLP-1WegovyZepboundSaxenda
Visit 9amHealth
7.5

Signos

Best for Pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app
★★★3.8

Starting at $199/mo

CompoundedSemaglutideCGM + App IncludedFDA-Cleared CGM
Visit Signos

Side-by-Side Comparison

Feature9amHealthSignos
Overall Score7.6/107.5/10
Starting Price$149/mo$199/mo
Editorial Rating3.8 ★ /53.8 ★ /5
Features7 features8 features
States Available00
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted✓ Yes
FDA WarningsNoneNone

Pros & Cons

9amHealth

Pros

  • Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound, Saxenda)
  • $149/month membership or free when covered by insurance
  • Membership includes specialists, labs, devices, and medications
  • Board-certified obesity specialists (DABOM), endocrinologists, dietitians, PharmDs
  • Helps navigate insurance approvals; employer and state-plan partnerships
  • Home lab draws available in some areas
  • Cardiometabolic whole-body care beyond weight loss

Cons

  • Medication coverage and GLP-1 access depend on insurance and BMI criteria
  • State availability not enumerated on the public site
  • Branded GLP-1s can be costly without insurance coverage
  • Pricing for medications not transparently listed

Signos

Pros

  • Bundles compounded GLP-1 (semaglutide) with an FDA-cleared CGM and app — glucose-guided weight loss, not just medication
  • Starting at $199/mo on a 6-month program, with the CGM included at no extra cost
  • Free rapid shipping; HSA/FSA eligible
  • Real-time glucose insights and app coaching to help sustain results after GLP-1

Cons

  • Compounded GLP-1s are not FDA-approved finished products
  • Headline price is a 6-month-program rate, not month-to-month
  • Only semaglutide is shown in the program; tirzepatide availability is not confirmed
  • Compounding pharmacy partner and state availability are not published on the landing page

Our Verdict

Winner: 9amHealthScore: 7.6/10

9amHealth edges out Signos with a higher overall score of 7.6/10 and is particularly strong for Insured patients wanting branded GLP-1s within a full cardiometabolic care program. Signos remains a solid alternative, especially if you're looking for Pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app.

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring 9amHealth and Signos head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.